INS and type 2 diabetes mellitus: It could be hypothesised that reduced insulin secretion (in T1DM) and impaired insulin sensitivity (in T2DM) are associated with a higher expression of Wnt inhibitors or lower expression of β-catenin, causing impaired bone health in T1DM, T2DM, and/or obese individuals.